Consistently, the majority of population-based studies on the PON1 phenotype, found that low enzymatic activity is associated with T2D and related clinical complications, and this, in turn, could be due to the increased levels of pro-atherogenic oxidized LDL and HDL of these patients [28,29,30,31]. Here, PON1 is linked to type 2 diabetes mellitus.